Epstein–Barr Virus: More than Just an Infection
Viruses · 2026
DOI: 10.3390/v18091048 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Viruses, 2026. Verfasst von Evelyn Van de Perre und 2 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, UCLouvain, 59 Promenade de l'Alma, 1200 Brussels, Belgium. Hauptthemen laut MEDLINE: Epstein-Barr Virus Infections, Herpesvirus 4, Human. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
While typically associated with benign infectious mononucleosis, Epstein–Barr virus (EBV) is now recognized as a pivotal driver of complex immunopathological disorders. By shuttling between lytic replication and strategic latency programs, EBV reprograms B-cell biology to evade immune surveillance and disrupt homeostasis. Central to this pathogenesis is the viral protein EBNA1, which triggers autoimmunity through molecular mimicry with host antigens, including GlialCAM in multiple sclerosis (MS), keratin in rheumatoid arthritis, and nuclear proteins in systemic lupus erythematosus. These autoimmune responses are further exacerbated by bystander activation and epitope spreading, fueling chronic inflammation in Crohn’s disease, type 1 diabetes, and IgA nephropathy. EBV can also promote the development of lymphoproliferative disorders, whether in immunocompetent hosts or in the context of immunosuppression; however, the emergence of EBV-positive forms within diseases that are usually EBV-negative is closely linked to an underlying state of immunosuppression. Distinct from these chronic states, EBV-associated hemophagocytic lymphohistiocytosis (HLH) represents a critical hyperinflammatory emergency in which defective cytotoxicity leads to an uncontrolled T-cell- or NK-cell-driven cytokine storm; together with chronic active EBV disease (CAEBV), HLH disproportionately affects children, and both receive particular attention in this review. More recently, emerging but not yet consolidated evidence has also suggested a possible association between EBV reactivation and long COVID. Elucidating these diverse molecular interactions is essential for developing the next generation of targeted therapies and vaccine strategies aimed at mitigating the systemic impact of this virus.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Medicine, UCLouvain, 59 Promenade de l'Alma, 1200 Brussels, Belgium.
- Department of Internal Medicine and Infectious Diseases, Cliniques Universitaires Saint-Luc, UCLouvain, 10 Avenue Hippocrate, 1200 Brussels, Belgium.
ORCID-Profile: Jean Cyr Yombi
Zitieren
APA
Van de Perre, E., Van Nieuwenhuyse, B., & Yombi, J. C. (2026). Epstein–Barr Virus: More than Just an Infection. Viruses. https://doi.org/10.3390/v18091048
Vancouver
Van de Perre E, Van Nieuwenhuyse B, Yombi JC. Epstein–Barr Virus: More than Just an Infection. Viruses. 2026. doi:10.3390/v18091048
BibTeX
@article{VandePerre2026,
author = {Van de Perre, Evelyn and Van Nieuwenhuyse, Brieuc and Yombi, Jean Cyr},
title = {Epstein–Barr Virus: More than Just an Infection},
journal = {Viruses},
year = {2026},
doi = {10.3390/v18091048}
}
EUVIMED